FTRE
Price
$5.91
Change
-$0.36 (-5.74%)
Updated
Jun 13 closing price
Capitalization
535.09M
65 days until earnings call
XNCR
Price
$9.19
Change
-$0.24 (-2.55%)
Updated
Jun 13 closing price
Capitalization
654.06M
46 days until earnings call
Interact to see
Advertisement

FTRE vs XNCR

Header iconFTRE vs XNCR Comparison
Open Charts FTRE vs XNCRBanner chart's image
Fortrea Holdings
Price$5.91
Change-$0.36 (-5.74%)
Volume$2.99M
Capitalization535.09M
Xencor
Price$9.19
Change-$0.24 (-2.55%)
Volume$421.64K
Capitalization654.06M
FTRE vs XNCR Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. XNCR commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (FTRE: $5.91 vs. XNCR: $9.19)
Brand notoriety: FTRE and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 100% vs. XNCR: 44%
Market capitalization -- FTRE: $535.09M vs. XNCR: $654.06M
FTRE [@Biotechnology] is valued at $535.09M. XNCR’s [@Biotechnology] market capitalization is $654.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both FTRE and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 6 bullish TA indicator(s).

  • FTRE’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а +11.93% price change this week, while XNCR (@Biotechnology) price change was -4.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

FTRE is expected to report earnings on Aug 18, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($654M) has a higher market cap than FTRE($535M). XNCR YTD gains are higher at: -60.009 vs. FTRE (-68.311). FTRE has higher annual earnings (EBITDA): -64.3M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. FTRE (118M). XNCR has less debt than FTRE: XNCR (67.8M) vs FTRE (1.2B). FTRE has higher revenues than XNCR: FTRE (2.7B) vs XNCR (127M).
FTREXNCRFTRE / XNCR
Capitalization535M654M82%
EBITDA-64.3M-161.68M40%
Gain YTD-68.311-60.009114%
P/E RatioN/AN/A-
Revenue2.7B127M2,123%
Total Cash118M470M25%
Total Debt1.2B67.8M1,767%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREXNCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 5 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 9 days ago
72%
Declines
ODDS (%)
Bearish Trend about 1 month ago
84%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAFSX36.05N/A
N/A
Fidelity Advisor Financials M
BIGRX36.84N/A
N/A
American Century Discplnd Cor Val Inv
JNBCX10.03N/A
N/A
JPMorgan Income Builder C
ARAOX11.91N/A
N/A
Aristotle/Saul Global Eq A
CCAFX36.51-0.58
-1.56%
Calvert Mid-Cap A

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with TECH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-5.74%
TECH - FTRE
40%
Loosely correlated
-1.96%
BHVN - FTRE
39%
Loosely correlated
-0.83%
DNLI - FTRE
39%
Loosely correlated
-2.51%
OCUL - FTRE
37%
Loosely correlated
-2.46%
XNCR - FTRE
37%
Loosely correlated
-2.55%
More